Table 2.
Recommended intervals for screening children of an affected parent.
| Ophthalmological examination yearly from infancy |
|---|
| Neurological examination yearly from infancy |
| Audiology with auditory brainstem evoked potentials yearly from infancy |
| Presymptomatic genetic testing; one test from 10 years of agea |
| Cranial magnetic resonance imaging (MRI) at 10–12 years of agea |
| Spinal MRI at 10–12 years of age (every 2–3 years) |
a
Before 10 years of age in severely affected families and families for which early detection would aid in the preparation for future events related to neurofibromatosis type 2.